Nurix Therapeutics NRIX
NASDAQ NRIX
$23.67 +0.00 (+0.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Capital Expenditures (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) recorded Capital Expenditures of $1.94 million in fiscal Q2 2026 (quarter ended May 31, 2026), down 27.6% from $2.68 million a year earlier but up 85.3% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Capital Expenditures (2019 - 2026) Analysis & Trends

On a TTM basis, Nurix Therapeutics' Capital Expenditures came in at $10.82 million as of May 31, 2026, up 2.0% year-over-year; for FY2025 (ended Nov 30, 2025), it was $14 million, up 51.0% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
  • Across earlier fiscal years, Capital Expenditures came in at $9.27 million in FY2024 (+10.4%), $8.4 million in FY2023 (-31.4%), $12.24 million in FY2022 (+116.3%) and $5.66 million in FY2021 (+24.3%).
  • Quarterly Capital Expenditures has ranged from $862,000 in fiscal Q4 2021 to $5.13 million in fiscal Q4 2025 over the past five years.
  • On a year-over-year basis, Capital Expenditures rose in four of the last eight quarters, with growth averaging 12.2%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 311.9% in fiscal Q1 2022, against a decline of 70.0% in fiscal Q1 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $1.05 million (Q1 2026), $5.13 million (Q4 2025) and $2.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Nurix Therapeutics 2.45 Bn 448.58 Mn - 1.94 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 1.94 Mn
Feb 28, 2026 1.05 Mn
Nov 30, 2025 5.13 Mn
Aug 31, 2025 2.71 Mn
May 31, 2025 2.68 Mn
Feb 28, 2025 3.49 Mn
Nov 30, 2024 2.11 Mn
Aug 31, 2024 2.35 Mn
May 31, 2024 1.94 Mn
Feb 29, 2024 2.88 Mn
Nov 30, 2023 2.59 Mn
Aug 31, 2023 2.46 Mn
May 31, 2023 1.08 Mn
Feb 28, 2023 2.28 Mn
Nov 30, 2022 2.57 Mn
Aug 31, 2022 3.42 Mn
May 31, 2022 2.79 Mn
Feb 28, 2022 3.47 Mn
Nov 30, 2021 862,000.00
Aug 31, 2021 1.87 Mn
API Access

Nurix Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NRIX&period=max&api_key=YOUR_API_KEY